Form 4: Collegium Pharmaceutical EVP Colleen Tupper Reports Changes in Beneficial Ownership

Colleen Tupper, EVP & Chief Financial Officer of Collegium Pharmaceutical, reports acquisition and disposal of common stock and derivative securities.

Summary

• Colleen Tupper, the EVP & Chief Financial Officer of Collegium Pharmaceutical, filed a Form 4 detailing changes in her beneficial ownership of the company's securities.
• On February 10, 2025, Tupper acquired 51,768 shares of common stock through restricted stock units (RSUs) and 26,957 shares through performance share units (PSUs).
• Also on February 10, 2025, 8,109 shares were withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs at a price of $30.52.
• Additionally, 22,317 shares were withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs at a price of $30.52.
• Following these transactions, Tupper beneficially owns 179,144 shares of Collegium Pharmaceutical common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects routine transactions related to executive compensation. The vesting of PSUs suggests the company met certain performance criteria, which is mildly positive.

Positives

• The grant of RSUs and vesting of PSUs indicate continued alignment of executive compensation with company performance and shareholder value.

Negatives

• The withholding of shares to cover taxes reduces the net increase in Tupper's holdings.

Future Outlook

The RSUs vest over a three-year period, indicating a long-term incentive for the reporting person.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track executive sentiment and potential alignment with company performance.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units to incentivize performance and align executive interests with those of shareholders.
• Vesting schedules for RSUs and PSUs are common, typically ranging from one to five years, depending on the company's goals and industry practices.
• Tax withholding upon vesting of equity awards is a standard practice to cover the executive's tax obligations.

Stakeholder Impact

• Shareholders can monitor insider transactions to gauge executive confidence and alignment with company goals.
• Employees may be impacted by the company's performance, which affects the vesting of PSUs.

Key Dates